Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables
/in Dendritic Cells, Glioblastoma, International Publications /von 2018-12-05 / Acta Neuropathol Commun 2018 12;6(1):135Immunotherapy in acute myeloid leukemia and myelodysplastic syndromes: The dawn of a new era?
/in Acute Leukemia, Dendritic Cells, International Publications /von 2018-12-05 / Blood Rev. 2019 03;34:67-83Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study
/in Dendritic Cells, Gastric Cancer, International Publications /von 2018-12-04 / Clin. Cancer Res. 2019 Mar;25(5):1494-1504Current State of Dendritic Cell-Based Immunotherapy: Opportunities for Antigen Loading of Different DC Subsets?
/in Dendritic Cells, International Publications /von 2018-12-03 / Front Immunol 2018;9:2804Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies?
/in Dendritic Cells, International Publications /von 2018-11-23 / Vaccines (Basel) 2018 Nov;6(4)Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapy
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2018-11-21 / Clin Transl Oncol 2019 Jun;21(6):774-780The Dilemma of Cure and Damage in Oligodendroglioma: Ways to Tip the Balance Away from the Damage
/in Dendritic Cells, Glioblastoma, International Publications /von 2018-11-12 / Cancers (Basel) 2018 Nov;10(11)Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients‘ preference-based study (PPPS)
/in Dendritic Cells, International Publications, NSCLC /von 2018-10-29 / Clin Transl Oncol 2019 Jun;21(6):721-728Empowering dendritic cell cancer vaccination: the role of combinatorial strategies
/in Dendritic Cells, International Publications /von 2018-10-22 / Cytotherapy 2018 Nov;20(11):1309-1323
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de